New biotech directions provide significant opportunity for electronic medicine. The article below focuses on altering genes to stop replication of AIDs virus, cancer cells, and so forth. However, the genes simply stop creation of proteins and electromagnetic fields can eliminate these same proteins.

In future years, researchers will find that genetic engineering can be accomplished more easily with electromagnetic fields. Meanwhile, electromedicine researchers can focus on identifying specific proteins causing health problems and knock them out with a frequency device.

RNAi Therapy

Thomas Tuschl

10 Emerging Technologies That Will Change Your World

MIT Technology Review, February 2004

From heart disease to hepatitis, cancer to AIDS, a host of modern ailments are triggered by our own errant genes—or by those of invading organisms. So if a simple technique could be found for turning off specific genes at will, these diseases could—in theory—be arrested or cured. Biochemist Thomas Tuschl may have found just such an off switch in humans: RNA interference (RNAi). While working at Germany’s Max Planck Institute for Biophysical Chemistry, Tuschl discovered that tiny double-stranded molecules of RNA designed to target a certain gene can, when introduced into human cells, specifically block that gene’s effects.

Psychologists offer proof of brain’s ability to suppress memories

BY Lisa Trei

Stanford Report, Jan. 8, 2004

For the first time, researchers at Stanford University and the University of Oregon have shown that a biological mechanism exists in the human brain to block unwanted memories.

The findings, published Jan. 9 in the journal Science, reinforce Sigmund Freud’s controversial century-old thesis about the existence of voluntary memory suppression.

“The big news is that we’ve shown how the human brain blocks an unwanted memory, that there is such a mechanism and it has a biological basis,” said Stanford psychology Professor John Gabrieli, a co-author of the paper titled “Neural Systems Underlying the Suppression of Unwanted Memories.” “It gets you past the possibility that there’s nothing in the brain that would suppress a memory — that it was all a misunderstood fiction.”

The experiment showed that people are capable of repeatedly blocking thoughts of experiences they don’t want to remember until they can no longer retrieve the memory, even if they want to, Gabrieli explained.

One of the primary reasons for my interest in electronic medicine is simply to protect family and friends from the day when antibiotics become useless due to ignorance, apathy, and business driven imperatives. That day may come sooner than we expect due to the way genetic engineering is done. It is not that genetic engineering is bad, it is that it is used in ways that are designed to produce antibiotic resistance strains. Charlotte Boehme reports on this in the Rife Forum.

————-

For a long time I have been reading that somehow, genetic engineering can cause bacterial resistance to antibiotics – but never quite understood exactly how or why.  This week I came across an article that explains it quite clearly.  The problem originates in the manufacturing process and goes something like this…

– at the beginning stage of modifying the DNA of the target cells, the cells don’t easily uptake the material that the people want inserted into the genome.  The article states that “fewer than 1 in every 1000 or even 1 in every 100,000 cells is modified during the process itself.”  In

other words, it’s the exception rather than the rule when they get a “take-up” by a cell.

– in order to identify which cells had a good takeup of the genetically modified material, in most instances they include in the GM material a gene that codes for antibiotic resistance.  So not only is the desired new trait going into a cell, but also antibiotic resistance.

– initially, all the cells with or without a “take” are cultured, but the the culture media itself contains an antibiotic.  Thus the cells with no “take-up” of genetically modified material are killed off, and only the cells with a “take” survive the culture conditions.  The antibiotic provides the necessary selection for the manufacturing process.

– the antibiotic resistance gene makes its way – along with the other GM material – into the future plant material, is eaten by animals, gets into the digestive tract and perhaps other areas of the body.  The DNA for the antibiotic resistance can then be transmitted into the DNA of the bacteria within the body (this process is called “horizontal transmission” and is well-documented).  The antibiotic resistance gene(s) may also make their way into other areas of the environment.

Considering these things, one is forced to wonder whether the outbreaks of severely pathogenic bacteria in the meat supply are being supported by the presence of the antibiotic resistance gene(s) in the animals’ food supply.  And whether our policy makers are truly aware of this problem.

The entire article mentioned above by Dr. Narash Harang, is easy to understand and worth the read … with the full article being at

Charlotte Boehme

Rife Forum

Vitamin D intake and incidence of multiple sclerosis

K. L. Munger, MSc, S. M. Zhang, MD ScD, E. O’Reilly, MSc, M. A. Hernán, MD DrPH, M. J. Olek, DO, W. C. Willett, MD DrPH and A. Ascherio, MD DrPH

NEUROLOGY 2004;62:60-65

Background: A protective effect of vitamin D on risk of multiple sclerosis (MS) has been proposed, but no prospective studies have addressed this hypothesis.

Methods: Dietary vitamin D intake was examined directly in relation to risk of MS in two large cohorts of women: the Nurses’ Health Study (NHS; 92,253 women followed from 1980 to 2000) and Nurses’ Health Study II (NHS II; 95,310 women followed from 1991 to 2001). Diet was assessed at baseline and updated every 4 years thereafter. During the follow-up, 173 cases of MS with onset of symptoms after baseline were confirmed.

Results: The pooled age-adjusted relative risk (RR) comparing women in the highest quintile of total vitamin D intake at baseline with those in the lowest was 0.67 (95% CI = 0.40 to 1.12; p for trend = 0.03). Intake of vitamin D from supplements was also inversely associated with risk of MS; the RR comparing women with intake of DER=”0″>400 IU/day with women with no supplemental vitamin D intake was 0.59 (95% CI = 0.38 to 0.91; p for trend = 0.006). No association was found between vitamin D from food and MS incidence.

Conclusion: These results support a protective effect of vitamin D intake on risk of developing MS.

The EPA has chosen not to regulate Bacillus licheniformus, which was recently identified by British researchers as the Rife “cancer germ” through DNA sequencing of multiple pleomorphic forms of this organism. This organism appears to be a mutagen and tumor promoter, is sold in many probiotic nutritional products, and is extremely hazardous. Eliminating this organism is the first step in dealing with any form of cancer and it appears in virtually all cancer patients. This is documented extensively in my archives.

Fortunately, the researchers have isolated the enzyme produced by Bacillus licheniformus that degrades Mad Cow prions. Unfortunately, the ignorant may promote putting Bacillus licheniformus in animal feed and expose us to signficantly increased risk of cancer. I strongly recommend you avoid any food that may be contaminated by Baccilus licheniformus. I’ve found this in animal meats, certain oils, as well as in probiotic supplements. Fortunately, in the case of some probiotics, they list it on the package as an ingredient, so the knowledgeable can avoid this hazard in some cases.

It would be interesting to followup these researchers over the years as they may have infected themselves with Bacillus Licheniformus and be at high risk of developing cancer.

Enzymatic degradation of prion protein in brain stem from infected cattle and sheep

Langeveld JP, Wang JJ, Van de Wiel DF, Shih GC, Garssen GJ, Bossers A, Shih JC.

J Infect Dis. 2003 Dec 1;188(11):1782-9.

Prions-infectious agents involved in transmissible spongiform encephalopathies-normally survive proteolytic and mild protein-destructive processes. Using bacterial keratinase produced by Bacillus licheniformis strain PWD-1, we tested conditions to accomplish the full degradation of prion protein (PrP) in brain-stem tissue from animals with bovine spongiform encephalopathy and scrapie. The detection of PrPSc, the disease-associated isoform of PrP, in homogenates was done by Western blotting and various antibodies. The results indicated that only in the presence of detergents did heat pretreatment at >100 degrees C allow the extensive enzymatic breakdown of PrPSc to a state where it is immunochemically undetectable. Proteinase K and 2 other subtilisin proteases, but not trypsin and pepsin, were also effective. This enzymatic process could lead to the development of a method for the decontamination of medical and laboratory equipment. The ultimate effectiveness of this method of prion inactivation has to be tested in mouse bioassays.

Click here for updates and comments

The revolutionary

Donald Berwick says our nation’s world-class hospitals and doctors are delivering health care that is unsafe and unreliable. But his call to dismantle the system makes the medical establishment uneasy — especially since he used to be part of it.

By Neil Swidey, Globe Staff, 1/4/2004

… Every year, up to 98,000 people are believed to die in American hospitals because of medical mistakes. The studies that provided the basis for that chilling estimate were not Berwick’s, yet no one has done more to ensure that the findings remain at the top of the national health care agenda. And Berwick is committed to doing more than just sounding alarms. He believes health care can be dramatically improved if it takes to heart the systems-improvement work that has transformed other industries, and if it focuses on eliminating the danger, waste, confusion, and arrogance that are pulling medicine down. He and his institute are working with several hundred health care organizations, large and small, in an effort to post results that would back up his theories. The swelling ranks of Berwick’s acolytes speak of him in almost messianic terms. “Don Berwick should win the Nobel Prize for Medicine,” says Blair Sadler, who runs San Diego Children’s Hospital. “I think he has saved more lives than any doctor alive today.”

But the deeper Berwick has gotten into the problem over the last decade, the more radicalized he has become. At this point, mild-mannered, soft-spoken, self-effacing 57-year-old Don Berwick can best be described as a revolutionary. A lot of people say the current health care system is broken, but by that they mean the manner of financing it. Berwick gets irritated when health care leaders complain about a lack of resources. There’s too much money in the system already, he says. His critique takes aim at the medical profession’s exalted view of itself. He’s convinced that the fundamentals of the current system — the same fundamentals Boston used to build its reputation as the world’s medical leader — are so screwed up that it is no longer possible for the medical profession to provide reliable, high-quality care, no matter how many innovations its renowned doctors roll out, no matter how many awards they rack up. “They want to cure cancer,” Berwick says. “Well, how about curing health care?”

His conclusion: To save the health care system, it first needs to be blown up.

his is what health care would look like if Don Berwick ruled the world, rather than just traveled it:

When you wanted to see your doctor, you would call in the morning and get an appointment that afternoon. And it would start on time, not an hour and three outdated People magazines later.

You would maintain control of your medical record, rather than needing a subpoena just to get a peek at it.

Hospitals would have genuine one-stop registration, and every employee would be trained to have the customer-service touch of a Ritz-Carlton concierge. No one would ask you to wear one of those open-backed johnnies.

Waiting would be kept to a minimum, because the hospital will have embraced flow management, anticipating rather than just reacting. There would be no visiting hours in the intensive care unit, since any family member could visit at any time.

Medication errors — overdoses, allergic reactions, and other adverse responses — would be all but eliminated by the universal adoption of computerized drug-ordering systems. Hospitals would impose a zero-tolerance policy for workers failing to wash their hands, a move that could save upward of 10,000 lives a year.

Communication and patient-advocacy systems would put an end to horror stories like the one involving the 5-year-old boy who died at Children’s Hospital last year because each of his many doctors assumed another doctor was in charge.

Waste would be systematically reduced. Hospital performance would become so transparent that finding the best place to get an operation would be almost as easy as shopping for a new TV online.

And the treatment you receive from your doctors would be made far more effective by a system that gave them less discretion. Physician habit and ego would take a back seat to science in determining standardized courses of medical action. Berwick argues that in terms of improving safety, health care could learn a lot from aviation, where commercial pilots have much less discretion than they used to.

Electronic medicine takes many forms. Information at the point of care can radically reduce medical error, the third leading cause of death in the United States. The largest component of medical error is caused by medication error, by itself the fourth leading cause of death. Computer Physician Order Entry (CPOE) can reduce medication error by over 95% in pediatric critical care units. Currently, only about 6% of healthcare institutions use these systems in the U.S. and only a small fraction of those have more than 50% of physicians actually using CPOE.

PEDIATRICS Vol. 113 No. 1 January 2004, pp. 59-63

Computerized Physician Order Entry and Medication Errors in a Pediatric Critical Care Unit

Amy L. Potts, PharmD, Frederick E. Barr, MD, MSCI, David F. Gregory, PharmD, BCPS, Lorianne Wright, PharmD and Neal R. Patel, MD, MPH

Objective. Medication errors are a major concern of health care professionals and medical institutions, especially errors involving children. Studies in adults have shown that computerized physician order entry (CPOE) systems reduce medication errors and adverse drug events (ADEs). The effect of CPOE implementation in a pediatric population has not been reported. The objective of this study was to evaluate the impact of CPOE on the frequency of errors in the medication ordering process in a pediatric critical care unit (PCCU).

Methods. A prospective trial was conducted of 514 pediatric patients who were admitted to a 20-bed PCCU in a tertiary-ethods.care children’s hospital before and after implementation of CPOE. Medication errors were identified after review of all orders during the study period and then further classified as potential ADEs, medication prescribing errors (MPE), and rule violations (RV).

Results. A total of 13 828 medication orders were reviewed. Before implementation, potential ADEs occurred at a rate of 2.2 per 100 orders, MPEs at a rate of 30.1 per 100 orders, and RVs at a rate of 6.8 per 100 orders. After implementation, the rate of potential ADEs was reduced to 1.3 per 100 orders, MPEs to 0.2 per 100 orders, and RVs to 0.1 per 100 orders. The overall error reduction was 95.9%. Potential ADEs were reduced by 40.9%, and MPEs and RVs were reduced by 99.4% and 97.9%, respectively.

Conclusions. The implementation of CPOE resulted in almost a complete elimination of MPEs and RVs and a significant but less dramatic effect on potential ADEs.

Today, I was asked for biological evidence of the mechanism for homeopathy. Homeopathy clearly works as I use it regularly and get remarkable results. Homeopathy, nutritional supplements, and electronic medicine have allowed me to avoid all drugs and antibiotics for over a decade now. As a more detailed example, Dr. Ramakrishnan has published data on thousands of his cancer patients showing more data and better results than most oncologists in our leading medical centers can muster. See:

Ramakrishnan, A.U. and Coulter, Catherine R. (2001) A Homeopathic Approach to Cancer. Quality Medical Publishing.

But how does it work and what can we find in the leading medical journals? Answering this question will take multiple postings so lets start with a review of the literature:

Clinical trials of homoeopathy.

Kleijnen J, Knipschild P, ter Riet G.

BMJ. 1991 Feb 9;302(6772):316-23.

OBJECTIVE–To establish whether there is evidence of the efficacy of homoeopathy from controlled trials in humans.

DESIGN–Criteria based meta-analysis. Assessment of the methodological quality of 107 controlled trials in 96 published reports found after an extensive search. Trials were scored using a list of predefined criteria of good methodology, and the outcome of the trials was interpreted in relation to their quality.

SETTING–Controlled trials published world wide.

MAIN OUTCOME MEASURES–Results of the trials with the best methodological quality. Trials of classical homoeopathy and several modern varieties were considered separately.

RESULTS–In 14 trials some form of classical homoeopathy was tested and in 58 trials the same single homoeopathic treatment was given to patients with comparable conventional diagnosis. Combinations of several homoeopathic treatments were tested in 26 trials; isopathy was tested in nine trials. Most trials seemed to be of very low quality, but there were many exceptions. The results showed a positive trend regardless of the quality of the trial or the variety of homeopathy used. Overall, of the 105 trials with interpretable results, 81 trials indicated positive results whereas in 24 trials no positive effects of homoeopathy were found. The results of the review may be complicated by publication bias, especially in such a controversial subject as homoeopathy.

CONCLUSIONS–At the moment the evidence of clinical trials is positive but not sufficient to draw definitive conclusions because most trials are of low methodological quality and because of the unknown role of publication bias. This indicates that there is a legitimate case for further evaluation of homoeopathy, but only by means of well performed trials.

Keijnan and coworkers note that “the subject of the efficacy of homeopathy can hardly be tackled without providing some plausible explanation as to its mechanism of action.” A good place to start studying this question is:

Bellavite, Paolo and Signorini, Andrea (1995) Homeopathy: A Frontier in Medical Science. North Atlantic Books.

Current research can only partly explain the phenomenon of homeopathy because the mechanism goes beyond the bounds of classical pharmacology. However, it has an interesting and remarkable connection to electronic medicine.

Any good homeopath can repeatedly product powerful effects with extremely dilute substances. The conventional scientific paradigm says that this cannot be true because there is no logical explanation for it. This “ostrich” effect is common in science and goes directly against the grain of the scientific method. If you set up a repeatable experiment that anyone can reproduce, the fact that you are ignorant of the mechanism does not disprove the experiment. It simply proves that your current conception of science is inadequate.

Icy claim that water has memory

19:00 11 June 03 Exclusive from New Scientist Print Edition

Claims do not come much more controversial than the idea that water might retain a memory of substances once dissolved in it. The notion is central to homeopathy, which treats patients with samples so dilute they are unlikely to contain a single molecule of the active compound, but it is generally ridiculed by scientists.

Holding such a heretical view famously cost one of France’s top allergy researchers, Jacques Benveniste, his funding, labs and reputation after his findings were discredited in 1988.

Yet a paper is about to be published in the reputable journal Physica A claiming to show that even though they should be identical, the structure of hydrogen bonds in pure water is very different from that in homeopathic dilutions of salt solutions. Could it be time to take the “memory” of water seriously?

Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A 2003, 323, 67-74.

Those of us working in electronic medicine known that frequencies can inhibit growth and destroy cancer cells. New research is continuing to document this effect.

ELF-Eletromagnetic Fields Inhibit the Proliferation of Human Cancer Cells and Induce Apoptosis

Lijun Pang, Nelly Traitcheva, Gislinde Gothe, Juan A. Camacho Gomez, Hermann Berg

Electromagnetic Biology and Medicine , Volume 21 , Issue 3

Abstract: Weak and low-frequency pulsating electromagnetic fields (ELF-MF) can be applied to change cell metabolism, if cells are treated in a specific range of frequency and amplitude. In our case, the influence on proliferation of human K562 cells has been studied by applying a sinusoidal 50 Hz field of magnetic flux densities (B) between 2 and 13 mT for 2 or 4 days. In repeating all runs three times—counting each day—no difference between experiment and control was found below 6 mT. However, stronger field amplitudes inhibit cell division and induce apoptosis and necrosis as shown by flow cytometry. Treatment with 10 mT decreases the number of living cells to only 2% of the control. This electromagnetically induced apoptosis may be a first step for a noninvasive treatment of cancer tissue for inhibition of its proliferation.
Click here for updates and comments